Effects of sphingosine-1-phosphate on pacemaker activity of interstitial cells of Cajal from mouse small intestine
- 229 Downloads
Interstitial cells of Cajal (ICC) are the pacemaker cells that generate the rhythmic oscillation responsible for the production of slow waves in gastrointestinal smooth muscle. Spingolipids are known to present in digestive system and are responsible for multiple important physiological and pathological processes. In this study, we are interested in the action of sphingosine 1-phosphate (S1P) on ICC. S1P depolarized the membrane and increased tonic inward pacemaker currents. FTY720 phosphate (FTY720P, an S1P1,3,4,5 agonist) and SEW 2871 (an S1P1 agonist) had no effects on pacemaker activity. Suramin (an S1P3 antagonist) did not block the S1P-induced action on pacemaker currents. However, JTE-013 (an S1P2 antagonist) blocked the S1P-induced action. RT-PCR revealed the presence of the S1P2 in ICC. Calphostin C (a protein kinase C inhibitor), NS-398 (a cyclooxygenase-2 inhibitor), PD 98059 (a p42/44 inhibitor), or SB 203580 (a p38 inhibitor) had no effects on S1P-induced action. However, c-jun NH2-terminal kinase (JNK) inhibitor II suppressed S1P-induced action. External Ca2+-free solution or thapsigargin (a Ca2+-ATPase inhibitor of endoplasmic reticulum) suppressed action of S1P on ICC. In recording of intracellular Ca2+ ([Ca2+]i) concentration using fluo-4/AM S1P increased intensity of spontaneous [Ca2+]i oscillations in ICC. These results suggest that S1P can modulate pacemaker activity of ICC through S1P2 via regulation of external and internal Ca2+ and mitogenactivated protein kinase activation.
Keywordsinterstitial cells of Cajal intestinal motility pacemaker activity sphingosine-1-phosphate
Unable to display preview. Download preview PDF.
- Alemany, R., Sichelschmidt, B., Zu Heringdorf, D.M., Lass, H., Van Koppen, C.J., and Jakobs, K.H. (2000). Stimulation of sphingosine-1-phosphate formation by the P2Y2 receptor in HL-60 cells: Ca2+ requirement and implication in receptor-mediated Ca2+ mobilization, but not MAP kinase activation. Mol. Pharmacol. 58, 491–497.PubMedGoogle Scholar
- Blom, T., Slotte, J.P., Pitson, S.M., and Törnquist, K. (2005). Enhan-cement of intracellular sphingosine-1-phosphate production by inositol 1, 4, 5-trisphosphate-evoked calcium mobilisation in HEK-293 cells: endogenous sphingosine-1-phosphate as a modulator of the calcium response. Cell. Signal. 17, 827–836.PubMedCrossRefGoogle Scholar
- Dragusin, M., Wehner, S., Kelly, S., Wang, E., Merrill Jr, A.H., Kalff, J.C., and Van Echten-Deckert, G. (2006). Effects of sphingosine-1-phosphate and ceramide-1-phosphate on rat intestinal smooth muscle cells: implications for postoperative ileus. FASEB J. 20, 1930–1932.PubMedCrossRefGoogle Scholar
- Hla, T. (2004). Physiological and pathological actions of sphingosine 1-phosphate. Semin. Cell Dev. Biol. 513–520.Google Scholar
- Nodai, A., Machida, T., Izumi, S., Hamaya, Y., Kohno, T., Igarashi, Y., Iizuka, K., Minami, M., and Hirafuji, M. (2007). Sphingosine 1-phosphate induces cyclooxygenase-2 via Ca2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells. Life Sci. 80, 1768–1776.PubMedCrossRefGoogle Scholar
- Salomone, S., Potts, E., Tyndall, S., Ip, P., Chun, J., Brinkmann, V., and Waeber, C. (2008). Analysis of sphingosine 1 phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br. J. Pharmacol. 153, 140–147.PubMedCrossRefGoogle Scholar